Showing results (1031-1040 of 2,523) with videos related to

Sort By:
Pageof 253
Inflammopharmacology|October 11, 2025
Targeting the senescence-associated secretory phenotype to modify osteoarthritis in agingMuhammad Afzal, M M Rekha, Samir Sahoo, et al.
Inflammopharmacology|October 11, 2025
Phlomoides molucelloides (Bunge) Salmaki essential oil: a traditional remedy revitalized for modern antimicrobial challengesMansureh Ghavam, Gianluigi Bacchetta, Ines Castangia, et al.
Inflammopharmacology|October 9, 2025
Fabrication of bergapten loaded microneedle patch and assessment of its anti-arthritic potential against complete Freund's adjuvant induced arthritis in Wistar ratQadeer Ahmad, Ammara Saleem, Zulcaif Ahmad, et al.
Inflammopharmacology|October 9, 2025
Evaluating pomegranate seed oil for potential topical applications: safety, anti-inflammatory activity and wound healing in skin cell modelsEduardo M Costa, Manuela Machado, Manuela Pintado, et al.
Inflammopharmacology|October 17, 2025
Trypsin inhibitor isolated from the seeds of Inga laurina (sw.) Willd decreased inflammatory and nociceptive responses in miceIluska Senna Bonfá, Dalila Dos Santos Lencina, Jéssica de Araújo Isaías Muller, et al.
Inflammopharmacology|October 4, 2025
Inflammation and immune biomarkers: new frontiers in understanding and managing diabetes complicationsPolu Picheswara Rao, Shubham Mishra, Jaya Gupta, et al.
Inflammopharmacology|October 4, 2025
Curcumin: multifaceted biological actions and therapeutic implications-a narrative reviewBehnam Ghorbani-Nejad, Matin Baghani, Sajad Amiri, et al.
Inflammopharmacology|October 1, 2025
The potential protective effect of Empagliflozin against Cisplatin-induced ovarian damage via upregulation of SIRT1/Nrf2 and amelioration ER StressMagda E El-Sayad, Sally E Abu-Risha, Sarah S El-Sisi, et al.
Inflammopharmacology|September 27, 2025
Inflammopharmacological perspectives on plant-derived compounds: ınteraction with monkeypox virus receptorsFaik Gökalp
Inflammopharmacology|September 29, 2025
Efficacy and safety of Mirikizumab in the treatment of moderate to severe inflammatory bowel diseases: a systematic review and updated meta-analysisJoel Gabin Konlack Mekontso, Joseph Yvan Bena Nnang, Samuel G J Fodop, et al.
Pageof 253